51. Treatable traits in copd – a proposed approach
- Author
-
Paula Simão, Miguel Guimarães, António Jorge Ferreira, João Cardoso, Ana Sofia Oliveira, Maria Sucena, and NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
- Subjects
future ,Pulmonary and Respiratory Medicine ,medicine.medical_specialty ,Exacerbation ,precision medicine ,Treatable traits strategy ,Primary care ,HSM PNEU ,treatable traits strategy ,Asthma* / therapy ,Pulmonary Disease, Chronic Obstructive ,SDG 3 - Good Health and Well-being ,Multidisciplinary approach ,Advanced disease ,medicine ,Initial treatment ,Humans ,COPD ,Intensive care medicine ,Future ,Individual heterogeneity ,business.industry ,Health Policy ,Precision medicine ,Public Health, Environmental and Occupational Health ,General Medicine ,Pulmonary Disease, Chronic Obstructive* / therapy ,Expert Opinion ,medicine.disease ,Asthma ,phased approach ,Phenotype ,Phased Approach ,business ,Phased approach ,Pulmonary Disease, Chronic Obstructive* / diagnosis - Abstract
Funding Information: Medical writing support for this article was provided by Paula Pinto, PhD, of PMA – Pharmaceutical Medicine Academy and was funded by Bial. All authors contributed equally to this work and should be considered co-first authors for this study. Funding Information: This article was funded by Bial. Bial provided all necessary scientific bibliography and funded medical writing support and publishing charges. The authors did not receive direct funding for the writing of this article. Publisher Copyright: © 2021 Cardoso et al. The well-recognized individual heterogeneity within COPD patients has led to a growing interest in greater personalization in the approach of these patients. Thus, the treatable traits strategy has been proposed as a further step towards precision medicine in the management of chronic airway disease, both in stable phase and acute exacerbations. The aim of this paper is to perform a critical review on the treatable traits strategy and propose a guide to approach COPD patients in the light of this new concept. An innovative stepwise approach is proposed – a multidisciplinary model based on two distinct phases, with the potential to be implemented in both primary care and hospital settings. The first phase is the initial and focused assessment of a selected subset of treatable traits, which should be addressed in all COPD patients in both settings (primary care and hospital). As some patients may present with advanced disease at diagnosis or may progress despite this initial treatment requiring a more specialized assessment, they should progress to a second phase, in which a broader approach is recommended. Beyond stable COPD, we explore how the treatable traits strategy may be applied to reduce the risk of future exacerbations and improve the management of COPD exacerbations. Since many treatable traits have already been related to exacerbation risk, the strategy proposed here represents an opportunity to be proactive. Although it still lacks prospective validation, we believe this is the way forward for the future of the COPD approach. publishersversion published
- Published
- 2021